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PRELIMINARY AND SHORT REPORT
FAILURE OF PYROMEN TO AFFECT THE DEVELOPMENT OF AN
ECZEMATOUS SENSITIZATION IN TIlE GUINEA PIG
ADOLPH ROSTENBERG, JR., M.D.
INTRODUCTION
Pyromen is a complex polysaccharide derived from pseudomonas aeruginosa. The mate-
rial was originally introduced because of its fever promoting abilities. Since then the
material in febrile and nonfebrile doses has been used in the treatment of allergic (1, 2, 3)
and dermatologic (4) conditions in which benefit was presumably attained because of stimu-
lation of the reticulo-endothelial system. In view of the obvious difficulties of assessing the
therapeutic value of any product for the aforementioned conditions, it was thought that a
more objective evaluation of the drug might be obtained by endeavoring to determine what
influence it would have, if any, on the development of an eczematous sensitization in the
guinea pig.
EXPERIMNNTAL
Twelve guinea pigs, weighing between 250 and 300 grams, were divided into two groups
of six each. The Pyromen group received 0.1 gamma of Pyromen* in 0.5 cc. of fluid intra-.
peritoneally three times a week. Pyromen as marketed was diluted 1:50 with saline in order
to obtain the above concentration. The control group was treated in an identical fashion
with the solvent used by the manufacturer to dissolve Pyromen, this being further diluted
1:50 with saline. The intraperitoneal injections were given three times a week throughout
the course of the experiment until the final test readings had been done. After two weeks
of the preliminary treatment with the Pyromen and the control, both groups were exposed
to sensitizing doses of 2:4 dinitrochlorobenzene (30% solution in acetone). Two drops of the
2:4 solution were rubbed into the skin on three occasions with one or two days elapsing
between each application. After another interval of two weeks both groups were now tested
with challenging doses of 2:4. The results were as given in the table.
CONCLUSIONS
Pyromen in the above dosage had no apparent effect on the development of an allergic
eczematous sensitization to 2:4 dinitrochlorobenzene in the guinea pig.
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TABLE I
:4 Dinitrochlorobenzene test
GUINEA PIG NO.
DILUTIONS IN ACETONE
1—1000 1—1200 1—1800 1—2000
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Control group
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NOTE: W = weak. The top entry for each pigis the 24 hour reading, and the bottom entry
is the 48 hour reading.
